Multiple bilobar liver metastases from uveal melanoma: What is the limit for surgical resection?

IF 1.7 Q4 GASTROENTEROLOGY & HEPATOLOGY
Gennaro Mazzarella, Samer Diab, Alice La Franca, Ecoline Tribillon, Olivier Soubrane
{"title":"Multiple bilobar liver metastases from uveal melanoma: What is the limit for surgical resection?","authors":"Gennaro Mazzarella, Samer Diab, Alice La Franca, Ecoline Tribillon, Olivier Soubrane","doi":"10.14701/ahbps.25-131","DOIUrl":null,"url":null,"abstract":"<p><p>The primary clinical factor influencing survival in uveal melanoma (UM) is the onset of liver metastases. Managing uveal melanoma liver metastases (UMLM) remains difficult, as conventional systemic therapies infrequently yield durable responses and are linked with poor outcomes. Nonetheless, liver surgery continues to be the preferred strategy for improving prognosis in patients with potentially resectable metastases. Additionally, under certain conditions, debulking of the tumor has demonstrated effectiveness in delaying hepatic metastatic disease progression when it is technically achievable. This report describes our surgical approach to bilobar liver metastases from UM with hepatic vein infiltration, emphasizing both surgical techniques and outcomes, and explores the potential for maximal tumor reduction in UMLM following an extended disease-free interval between primary UM treatment and liver metastasis detection.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepato-biliary-pancreatic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14701/ahbps.25-131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The primary clinical factor influencing survival in uveal melanoma (UM) is the onset of liver metastases. Managing uveal melanoma liver metastases (UMLM) remains difficult, as conventional systemic therapies infrequently yield durable responses and are linked with poor outcomes. Nonetheless, liver surgery continues to be the preferred strategy for improving prognosis in patients with potentially resectable metastases. Additionally, under certain conditions, debulking of the tumor has demonstrated effectiveness in delaying hepatic metastatic disease progression when it is technically achievable. This report describes our surgical approach to bilobar liver metastases from UM with hepatic vein infiltration, emphasizing both surgical techniques and outcomes, and explores the potential for maximal tumor reduction in UMLM following an extended disease-free interval between primary UM treatment and liver metastasis detection.

葡萄膜黑色素瘤多发双叶肝转移:手术切除的限度是什么?
影响葡萄膜黑色素瘤(UM)生存的主要临床因素是肝转移的发生。治疗葡萄膜黑色素瘤肝转移(UMLM)仍然很困难,因为传统的全身治疗很少能产生持久的反应,而且预后差。尽管如此,肝脏手术仍然是改善潜在可切除转移患者预后的首选策略。此外,在某些条件下,当技术上可行时,肿瘤减积已被证明可有效延缓肝转移性疾病的进展。本报告描述了我们的手术方法,以治疗伴有肝静脉浸润的UM双叶肝转移,强调手术技术和结果,并探讨了在原发性UM治疗和肝转移检测之间延长无病间隔后,UMLM最大限度地减少肿瘤的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信